Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Adicet Bio, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +16 vs. Q1 2022
- Shares held
- 38.0M
- +4.95M (+15.0%) vs. Q1 2022
- Total value
- $555.9M
- −$103.5M (−15.7%) vs. Q1 2022
- New holders
- 32
- 35 more added
- Sold out
- 16
- 14 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACET on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $52.8M |
| Q1 2026 | 49 | $43.7M |
| Q4 2025 | 49 | $56.6M |
| Q3 2025 | 54 | $41.6M |
| Q2 2025 | 49 | $31.5M |
| Q1 2025 | 56 | $42.0M |
| Q4 2024 | 64 | $55.4M |
| Q3 2024 | 64 | $82.3M |
| Q2 2024 | 86 | $77.4M |
| Q1 2024 | 98 | $176.6M |
| Q4 2023 | 77 | $63.0M |
| Q3 2023 | 84 | $48.9M |
| Q2 2023 | 95 | $90.4M |
| Q1 2023 | 107 | $231.3M |
| Q4 2022 | 100 | $375.7M |
| Q3 2022 | 102 | $590.7M |
| Q2 2022 | 101 | $555.9M |
| Q1 2022 | 88 | $660.4M |
| Q4 2021 | 81 | $531.2M |
| Q3 2021 | 58 | $156.1M |
| Q2 2021 | 66 | $218.1M |
| Q1 2021 | 54 | $266.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Adicet Bio, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 7,447,141 | $108.7M | 2.11% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −3,120,000−100.0% | Sold out |
| Kingdon Capital Management, L.L.C. | 0 | $0 | 0.00% | −275,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −196,504−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −131,770−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −103,423−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −92,202−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −66,626−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −28,000−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −19,650−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −3,495−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,224−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −547−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |